Five-Year Forecast. The Committee will submit to DWT no later than the Effective Date an initial five-year forecast in quarters (the “Five-Year Forecast”) of Amylin’s anticipated purchase requirements of Devices for the U.S. and Lilly’s anticipated requirements for the Territory outside the U.S. Thereafter, the Committee will deliver to Lilly on an annual basis, a good faith forecast in quarters of the quantity of Devices Amylin expects to receive from Lilly during the Term of this Agreement. The Parties agree that the Five-Year Forecast will be used for planning purposes only and will not be binding on either Party.
Appears in 2 contracts
Sources: Device Development and Manufacturing Agreement (Amylin Pharmaceuticals Inc), Device Development and Manufacturing Agreement (Amylin Pharmaceuticals Inc)